SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Art Baer who wrote (852)8/12/1997 1:07:00 AM
From: William Presti   of 1172
 
They struck out on Choletrak? According to the Chemtrak,
they have been operating their Cholestrak manufacturing
shift (1 believe it is just one shift att) at capacity.
While it has been a difficult market to grow, it is
growing.

And I can't wait to see how things pan out for them
vis-a-vis Hp Chek and Astra Merck. A/M's Prilosec is
now the best selling drug in the world. And little ole
Chemtrak's H. Pylori test kit is going to be co-marketed
with it. Keep your fingers crossed for an August
announcement.

Now, while I don't think CMTR's stock is going to the moon
soon, I do expect it to be a safe bet that we will
see 2 or 3 multiple from present levels this year.

Hey, when was the shareholder meeting? Or is it still to come?
Would like to hear if Ed Covell and company have anything
to report about the private placement. Yes, it did take place
and was handled by Gruntal. The release we saw was to inform
that the item was dropped for shareholder voting purposes.
Time was of the essence.

Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext